Unity Biotechnology, Inc. (UBX) Misses Q1 EPS by 59c

Unity Biotechnology, Inc. (NASDAQ: UBX) reported Q1 EPS of ($0.76), $0.59 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Unity Biotechnology, Inc. (UBX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook